Cadila Healthcare on Tuesday announced that CRISIL has, after due deliberations, reaffirmed its rating of “CRISIL A1+” on the Rs1,300cr Commercial Paper of the company – Positive.
Feedback
ZYDUSLIFE 
Reputation: 263 • Sep 23, 2020 2:20 PM
Vote
Comment
Share
NSE:CADILAHC price when posted: 394.45